+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Pancreatic Cancer Treatment Market by Treatment Type (Chemotherapy, Immunotherapy, Palliative Care), Therapy Line (First Line, Fourth And Above, Second Line), End User, Distribution Channel - Global Forecast 2025-2030- Product Image
Pancreatic Cancer Treatment Market by Treatment Type (Chemotherapy, Immunotherapy, Palliative Care), Therapy Line (First Line, Fourth And Above, Second Line), End User, Distribution Channel - Global Forecast 2025-2030- Product Image
Sale

Pancreatic Cancer Treatment Market by Treatment Type (Chemotherapy, Immunotherapy, Palliative Care), Therapy Line (First Line, Fourth And Above, Second Line), End User, Distribution Channel - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 196 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5460172
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Pancreatic Cancer Treatment Market is rapidly evolving as innovation accelerates across therapy segments, diagnostics, and patient management—shaping an increasingly dynamic environment for stakeholders. Senior leaders must continuously adapt to changing market and regulatory conditions to capitalize on emerging opportunities and optimize outcomes.

Market Snapshot: Pancreatic Cancer Treatment Market Growth and Trends

The Pancreatic Cancer Treatment Market grew from USD 3.23 billion in 2024 to USD 3.69 billion in 2025. It is expected to continue growing at a CAGR of 13.35%, reaching USD 6.86 billion by 2030.

Scope & Segmentation

This report provides granular insights across leading therapeutic interventions, patient care strategies, and distribution models within the pancreatic cancer treatment market.

  • Treatment Type: Chemotherapy (Capecitabine, Folfirinox, Gemcitabine-Based), Immunotherapy (CAR T Therapy, Checkpoint Inhibitor, Vaccine Therapy), Palliative Care (Nutritional Support, Pain Management, Psychological Support), Radiation (Brachytherapy, External Beam Radiation, Stereotactic Body Radiation Therapy), Surgery (Distal Pancreatectomy, Total Pancreatectomy, Whipple Procedure), Targeted Therapy (EGFR Inhibitor, PARP Inhibitor)
  • Therapy Line: First Line, Second Line, Third Line, Fourth And Above
  • End User: Ambulatory Surgical Centers, Cancer Centers, Hospitals
  • Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy
  • Geographies: Americas (including United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), and Asia-Pacific (including China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan)
  • Industry Participants: F. Hoffmann-La Roche Ltd., Eli Lilly and Company, Bristol-Myers Squibb Company, Merck & Co., Inc., Novartis AG, Pfizer Inc., AstraZeneca PLC, Sanofi S.A., Johnson & Johnson, Amgen Inc.

Key Takeaways for Decision-Makers

  • Innovation in immuno-oncology and biomarker-driven approaches is reshaping response rates and introducing new standards of care across key regions.
  • Collaboration between pharma and biotech, supported by regulatory acceleration and evidence-generation initiatives, is sustaining pipeline velocity and expediting market entry for advanced therapies.
  • Personalized treatment protocols and digital health platforms, such as AI-driven diagnostics and real-time monitoring, are improving patient stratification and treatment adherence globally.
  • Surgical techniques are advancing with less invasive methods and perioperative optimization, expanding post-surgical recovery and eligibility for complex patient cohorts.
  • Comprehensive care models integrating systemic treatment, supportive services, and palliative care are emerging as a competitive differentiator for providers and pharmaceutical companies.
  • Segment leadership relies on aligning product lines with regional needs, as adoption and infrastructure vary widely between mature and emerging markets.

Tariff Impact: 2025 Policy Shifts and Distribution Strategies

Revised United States tariffs in 2025 have increased costs for critical oncology drugs and devices, prompting organizations to reassess international supply chains, explore nearshoring, and negotiate alternative sourcing to stabilize access. These changes have driven new approaches in pricing negotiations, highlighted the value of evidence-based reimbursement, and intensified the need for partnerships to expedite certifications and maintain business resilience.

Methodology & Data Sources

The findings are based on a hybrid research methodology combining comprehensive secondary research—peer-reviewed publications, trial registries, regulatory filings—and targeted primary interviews with oncologists, payers, clinical investigators, and supply chain specialists. Analytical tools include SWOT, technology adoption models, and value-chain mapping, ensuring accuracy and actionable insight backed by triangulated data.

Why This Report Matters

  • Empowers strategic planning with actionable intelligence on technological advancements, supply dynamics, and evolving care standards in the pancreatic cancer treatment market.
  • Equips executives to anticipate policy and reimbursement shifts, make informed R&D investments, and align operational initiatives with regionally specific needs.

Conclusion

The report helps decision-makers navigate the evolving pancreatic cancer treatment sector by distilling market complexity into actionable recommendations. Leaders equipped with this analysis can drive improved patient outcomes and reinforce strategic growth.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of circulating tumor DNA assays for early detection and minimal residual disease monitoring in pancreatic cancer patients
5.2. Commercial launch and market penetration strategies for novel KRAS G12C inhibitors targeting pancreatic adenocarcinoma
5.3. Adoption of combination immunotherapy regimens pairing PD-1 inhibitors with novel stromal targeting agents in pancreatic cancer
5.4. Development of next-generation CAR T-cell therapies addressing tumor microenvironment resistance in pancreatic cancer treatment
5.5. Increasing use of mRNA vaccine platforms to stimulate antitumor immunity in high-risk pancreatic cancer populations
5.6. Shift towards outpatient and home-based chemotherapy administration to improve patient quality of life and reduce hospital burden
5.7. Emergence of AI-driven predictive models for treatment response and survival outcomes in clinical management of pancreatic cancer
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Pancreatic Cancer Treatment Market, by Treatment Type
8.1. Introduction
8.2. Chemotherapy
8.2.1. Capecitabine
8.2.2. Folfirinox
8.2.3. Gemcitabine Based
8.3. Immunotherapy
8.3.1. Car T Therapy
8.3.2. Checkpoint Inhibitor
8.3.3. Vaccine Therapy
8.4. Palliative Care
8.4.1. Nutritional Support
8.4.2. Pain Management
8.4.3. Psychological Support
8.5. Radiation
8.5.1. Brachytherapy
8.5.2. External Beam Radiation
8.5.3. Stereotactic Body Radiation Therapy
8.6. Surgery
8.6.1. Distal Pancreatectomy
8.6.2. Total Pancreatectomy
8.6.3. Whipple Procedure
8.7. Targeted Therapy
8.7.1. Egfr Inhibitor
8.7.2. Parp Inhibitor
9. Pancreatic Cancer Treatment Market, by Therapy Line
9.1. Introduction
9.2. First Line
9.3. Fourth And Above
9.4. Second Line
9.5. Third Line
10. Pancreatic Cancer Treatment Market, by End User
10.1. Introduction
10.2. Ambulatory Surgical Centers
10.3. Cancer Centers
10.4. Hospitals
11. Pancreatic Cancer Treatment Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacy
11.3. Online Pharmacy
11.4. Retail Pharmacy
12. Americas Pancreatic Cancer Treatment Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Pancreatic Cancer Treatment Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Pancreatic Cancer Treatment Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. F. Hoffmann-La Roche Ltd.
15.3.2. Eli Lilly and Company
15.3.3. Bristol-Myers Squibb Company
15.3.4. Merck & Co., Inc.
15.3.5. Novartis AG
15.3.6. Pfizer Inc.
15.3.7. AstraZeneca PLC
15.3.8. Sanofi S.A.
15.3.9. Johnson & Johnson
15.3.10. Amgen Inc.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. PANCREATIC CANCER TREATMENT MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY THERAPY LINE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY THERAPY LINE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS PANCREATIC CANCER TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS PANCREATIC CANCER TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES PANCREATIC CANCER TREATMENT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES PANCREATIC CANCER TREATMENT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA PANCREATIC CANCER TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PANCREATIC CANCER TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC PANCREATIC CANCER TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC PANCREATIC CANCER TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. PANCREATIC CANCER TREATMENT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. PANCREATIC CANCER TREATMENT MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. PANCREATIC CANCER TREATMENT MARKET: RESEARCHAI
FIGURE 24. PANCREATIC CANCER TREATMENT MARKET: RESEARCHSTATISTICS
FIGURE 25. PANCREATIC CANCER TREATMENT MARKET: RESEARCHCONTACTS
FIGURE 26. PANCREATIC CANCER TREATMENT MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. PANCREATIC CANCER TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY CAPECITABINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY CAPECITABINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY FOLFIRINOX, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY FOLFIRINOX, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY GEMCITABINE BASED, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY GEMCITABINE BASED, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY CAR T THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY CAR T THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY CHECKPOINT INHIBITOR, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY CHECKPOINT INHIBITOR, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY VACCINE THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY VACCINE THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY PALLIATIVE CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY PALLIATIVE CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY NUTRITIONAL SUPPORT, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY NUTRITIONAL SUPPORT, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY PSYCHOLOGICAL SUPPORT, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY PSYCHOLOGICAL SUPPORT, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY PALLIATIVE CARE, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY PALLIATIVE CARE, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY RADIATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY RADIATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY BRACHYTHERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY BRACHYTHERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY EXTERNAL BEAM RADIATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY EXTERNAL BEAM RADIATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY STEREOTACTIC BODY RADIATION THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY STEREOTACTIC BODY RADIATION THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY RADIATION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY RADIATION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY SURGERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY SURGERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY DISTAL PANCREATECTOMY, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY DISTAL PANCREATECTOMY, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY TOTAL PANCREATECTOMY, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY TOTAL PANCREATECTOMY, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY WHIPPLE PROCEDURE, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY WHIPPLE PROCEDURE, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY SURGERY, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY SURGERY, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY TARGETED THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY TARGETED THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY EGFR INHIBITOR, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY EGFR INHIBITOR, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY PARP INHIBITOR, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY PARP INHIBITOR, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY THERAPY LINE, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY THERAPY LINE, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY FIRST LINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY FIRST LINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY FOURTH AND ABOVE, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY FOURTH AND ABOVE, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY SECOND LINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY SECOND LINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY THIRD LINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY THIRD LINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY CANCER CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY CANCER CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL PANCREATIC CANCER TREATMENT MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS PANCREATIC CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS PANCREATIC CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS PANCREATIC CANCER TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS PANCREATIC CANCER TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS PANCREATIC CANCER TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS PANCREATIC CANCER TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS PANCREATIC CANCER TREATMENT MARKET SIZE, BY PALLIATIVE CARE, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS PANCREATIC CANCER TREATMENT MARKET SIZE, BY PALLIATIVE CARE, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS PANCREATIC CANCER TREATMENT MARKET SIZE, BY RADIATION, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS PANCREATIC CANCER TREATMENT MARKET SIZE, BY RADIATION, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS PANCREATIC CANCER TREATMENT MARKET SIZE, BY SURGERY, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS PANCREATIC CANCER TREATMENT MARKET SIZE, BY SURGERY, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS PANCREATIC CANCER TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS PANCREATIC CANCER TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS PANCREATIC CANCER TREATMENT MARKET SIZE, BY THERAPY LINE, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS PANCREATIC CANCER TREATMENT MARKET SIZE, BY THERAPY LINE, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS PANCREATIC CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS PANCREATIC CANCER TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS PANCREATIC CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS PANCREATIC CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS PANCREATIC CANCER TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS PANCREATIC CANCER TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES PANCREATIC CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES PANCREATIC CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES PANCREATIC CANCER TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES PANCREATIC CANCER TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES PANCREATIC CANCER TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES PANCREATIC CANCER TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES PANCREATIC CANCER TREATMENT MARKET SIZE, BY PALLIATIVE CARE, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES PANCREATIC CANCER TREATMENT MARKET SIZE, BY PALLIATIVE CARE, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES PANCREATIC CANCER TREATMENT MARKET SIZE, BY RADIATION, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES PANCREATIC CANCER TREATMENT MARKET SIZE, BY RADIATION, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES PANCREATIC CANCER TREATMENT MARKET SIZE, BY SURGERY, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES PANCREATIC CANCER TREATMENT MARKET SIZE, BY SURGERY, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES PANCREATIC CANCER TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES PANCREATIC CANCER TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES PANCREATIC CANCER TREATMENT MARKET SIZE, BY THERAPY LINE, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES PANCREATIC CANCER TREATMENT MARKET SIZE, BY THERAPY LINE, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES PANCREATIC CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES PANCREATIC CANCER TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES PANCREATIC CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES PANCREATIC CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES PANCREATIC CANCER TREATMENT MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES PANCREATIC CANCER TREATMENT MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 139. CANADA PANCREATIC CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 140. CANADA PANCREATIC CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 141. CANADA PANCREATIC CANCER TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 142. CANADA PANCREATIC CANCER TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 143. CANADA PANCREATIC CANCER TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 144. CANADA PANCREATIC CANCER TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 145. CANADA PANCREATIC CANCER TREATMENT MARKET SIZE, BY PALLIATIVE CARE, 2018-2024 (USD MILLION)
TABLE 146. CANADA PANCREATIC CANCER TREATMENT MARKET SIZE, BY PALLIATIVE CARE, 2025-2030 (USD MILLION)
TABLE 147. CANADA PANCREATIC CANCER TREATMENT MARKET SIZE, BY RADIATION, 2018-2024 (USD MILLION)
TABLE 148. CANADA PANCREATIC CANCER TREATMENT MARKET SIZE, BY RADIATION, 2025-2030 (USD MILLION)
TABLE 149. CANADA PANCREATIC CANCER TREATMENT MARKET SIZE, BY SURGERY, 2018-2024 (USD MILLION)
TABLE 150. CANADA PANCREATIC CANCER TREATMENT MARKET SIZE, BY SURGERY, 2025-2030 (USD MILLION)
TABLE 151. CANADA PANCREATIC CANCER TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2024 (USD MILLION)
TABLE 152. CANADA PANCREATIC CANCER TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2025-2030 (USD MILLION)
TABLE 153. CANADA PANCREATIC CANCER TREATMENT MARKET SIZE, BY THERAPY LINE, 2018-2024 (USD MILLION)
TABLE 154. CANADA PANCREATIC CANCER TREATMENT MARKET SIZE, BY THERAPY LINE, 2025-2030 (USD MILLION)
TABLE 155. CANADA PANCREATIC CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 156. CANADA PANCREATIC CANCER TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 157. CANADA PANCREATIC CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 158. CANADA PANCREATIC CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 159. MEXICO PANCREATIC CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 160. MEXICO PANCREATIC CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 161. MEXICO PANCREATIC CANCER TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 162. MEXICO PANCREATIC CANCER TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 163. MEXICO PANCREATIC CANCER TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 164. MEXICO PANCREATIC CANCER TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 165. MEXICO PANCREATIC CANCER TREATMENT MARKET SIZE, BY PALLIATIVE CARE, 2018-2024 (USD MILLION)
TABLE 166. MEXICO PANCREATIC CANCER TREATMENT MARKET SIZE, BY PALLIATIVE CARE, 2025-2030 (USD MILLION)
TABLE 167. MEXICO PANCREATIC CANCER TREATMENT MARKET SIZE, BY RADIATION, 2018-2024 (USD MILLION)
TABLE 168. MEXICO PANCREATIC CANCER TREATMENT MARKET SIZE, BY RADIATION, 2025-2030 (USD MILLION)
TABLE 169. MEXICO PANCREATIC CANCER TREATMENT MARKET SIZE, BY SURGERY, 2018-2024 (USD MILLION)
TABLE 170. MEXICO PANCREATIC CANCER TREATMENT MARKET SIZE, BY SURGERY, 2025-2030 (USD MILLION)
TABLE 171. MEXICO PANCREATIC CANCER TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2024 (USD MILLION)
TABLE 172. MEXICO PANCREATIC CANCER TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2025-2030 (USD MILLION)
TABLE 173. MEXICO PANCREATIC CANCER TREATMENT MARKET SIZE, BY THERAPY LINE, 2018-2024 (USD MILLION)
TABLE 174. MEXICO PANCREATIC CANCER TREATMENT MARKET SIZE, BY THERAPY LINE, 2025-2030 (USD MILLION)
TABLE 175. MEXICO PANCREATIC CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 176. MEXICO PANCREATIC CANCER TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 177. MEXICO PANCREATIC CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 178. MEXICO PANCREATIC CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 179. BRAZIL PANCREATIC CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 180. BRAZIL PANCREATIC CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 181. BRAZIL PANCREATIC CANCER TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 182. BRAZIL PANCREATIC CANCER TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 183. BRAZIL PANCREATIC CANCER TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 184. BRAZIL PANCREATIC CANCER TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 185. BRAZIL PANCREATIC CANCER TREATMENT MARKET SIZE, BY PALLIATIVE CARE, 2018-2024 (USD MILLION)
TABLE 186. BRAZIL PANCREATIC CANCER TREATMENT MARKET SIZE, BY PALLIATIVE CARE, 2025-2030 (USD MILLION)
TABLE 187. BRAZIL PANCREATIC CANCER TREATMENT MARKET SIZE, BY RADIATION, 2018-2024 (USD MILLION)
TABLE 188. BRAZIL PANCREATIC CANCER TREATMENT MARKET SIZE, BY RADIATION, 2025-2030 (USD MILLION)
TABLE 189. BRAZIL PANCREATIC CANCER TREATMENT MARKET SIZE, BY SURGERY, 2018-2024 (USD MILLION)
TABLE 190. BRAZIL PANCREATIC CANCER TREATMENT MARKET SIZE, BY SURGERY, 2025-2030 (USD MILLION)
TABLE 191. BRAZIL PANCREATIC CANCER TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2024 (USD MILLION)
TABLE 192. BRAZIL PANCREATIC CANCER TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2025-2030 (USD MILLION)
TABLE 193. BRAZIL PANCREATIC CANCER TREATMENT MARKET SIZE, BY THERAPY LINE, 2018-2024 (USD MILLION)
TABLE 194. BRAZIL PANCREATIC CANCER TREATMENT MARKET SIZE, BY THERAPY LINE, 2025-2030 (USD MILLION)
TABLE 195. BRAZIL PANCREATIC CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 196. BRAZIL PANCREATIC CANCER TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 197. BRAZIL PANCREATIC CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 198. BRAZIL PANCREATIC CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 199. ARGENTINA PANCREATIC CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 200. ARGENTINA PANCREATIC CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 201. ARGENTINA PANCREATIC CANCER TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 202. ARGENTINA PANCREATIC CANCER TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 203. ARGENTINA PANCREATIC CANCER TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 204. ARGENTINA PANCREATIC CANCER TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 205. ARGENTINA PANCREATIC CANCER TREATMENT MARKET SIZE, BY PALLIATIVE CARE, 2018-2024 (USD MILLION)
TABLE 206. ARGENTINA PANCREATIC CANCER TREATMENT MARKET SIZE, BY PALLIATIVE CARE, 2025-2030 (USD MILLION)
TABLE 207. ARGENTINA PANCREATIC CANCER TREATMENT MARKET SIZE, BY RADIATION, 2018-2024 (USD MILLION)
TABLE 208. ARGENTINA PANCREATIC CANCER TREATMENT MARKET SIZE, BY RADIATION, 2025-2030 (USD MILLION)
TABLE 209. ARGENTINA PANCREATIC CANCER TREATMENT MARKET SIZE, BY SURGERY, 2018-2024 (USD MILLION)
TABLE 210. ARGENTINA PANCREATIC CANCER TREATMENT MARKET SIZE, BY SURGERY, 2025-2030 (USD MILLION)
TABLE 211. ARGENTINA PANCREATIC CANCER TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2024 (USD MILLION)
TABLE 212. ARGENTINA PANCREATIC CANCER TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2025-2030 (USD MILLION)
TABLE 213. ARGENTINA PANCREATIC CANCER TREATMENT MARKET SIZE, BY THERAPY LINE, 2018-2024 (USD MILLION)
TABLE 214. ARGENTINA PANCREATIC CANCER TREATMENT MARKET SIZE, BY THERAPY LINE, 2025-2030 (USD MILLION)
TABLE 215. ARGENTINA PANCREATIC CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 216. ARGENTINA PANCREATIC CANCER TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 217. ARGENTINA PANCREATIC CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 218. ARGENTINA PANCREATIC CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA PANCREATIC CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA PANCREATIC CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA PANCREATIC CANCER TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA PANCREATIC CANCER TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA PANCREATIC CANCER TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA PANCREATIC CANCER TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA PANCREATIC CANCER TREATMENT MARKET SIZE, BY PALLIATIVE CARE, 2018-2024 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA PANCREATIC CANCER TREATMENT MARKET SIZE, BY PALLIATIVE CARE, 2025-2030 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA PANCREATIC CANCER TREATMENT MARKET SIZE, BY RADIATION, 2018-2024 (USD MILLION)
TABLE 228. EUROPE, MIDDLE EAST & AFRICA PANCREATIC CANCER TREATMENT MARKET SIZE, BY RADIATION, 2025-2030 (USD MILLION)
TABLE 229. EUROPE, MIDDLE EAST & AFRICA PANCREATIC CANCER TREATMENT MARKET SIZE, BY SURGERY, 2018-2024 (USD MILLION)
TABLE 230. EUROPE, MIDDLE EAST & AFRICA PANCREATIC CANCER TREATMENT MARKET SIZE, BY SURGERY, 2025-2030 (USD MILLION)
TABLE 231. EUROPE, MIDDLE EAST & AFRICA PANCREATIC CANCER TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2024 (USD MILLION)
TABLE 232. EUROPE, MIDDLE EAST & AFRICA PANCREATIC CANCER TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2025-2030 (USD MILLION)
TABLE 233. EUROPE, MIDDLE EAST & AFRICA PANCREATIC CANCER TREATMENT MARKET SIZE, BY THERAPY LINE, 2018-2024 (USD MILLION)
TABLE 234. EUROPE, MIDDLE EAST & AFRICA PANCREATIC CANCER TREATMENT MARKET SIZE, BY THERAPY LINE, 2025-2030 (USD MILLION)
TABLE 235. EUROPE, MIDDLE EAST & AFRICA PANCREATIC CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 236. EUROPE, MIDDLE EAST & AFRICA PANCREATIC CANCER TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA PANCREATIC CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA PANCREATIC CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA PANCREATIC CANCER TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA PANCREATIC CANCER TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 241. UNITED KINGDOM PANCREATIC CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 242. UNITED KINGDOM PANCREATIC CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 243. UNITED KINGDOM PANCREATIC CANCER TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 244. UNITED KINGDOM PANCREATIC CANCER TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 245. UNITED KINGDOM PANCREATIC CANCER TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 246. UNITED KINGDOM PANCREATIC CANCER TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 247. UNITED KINGDOM PANCREATIC CANCER TREATMENT MARKET SIZE, BY PALLIATIVE CARE, 2018-2024 (USD MILLION)
TABLE 248. UNITED KINGDOM PANCREATIC CANCER TREATMENT MARKET SIZE, BY PALLIATIVE CARE, 2025-2030 (USD MILLION)
TABLE 249. UNITED KINGDOM PANCREATIC CANCER TREATMENT MARKET SIZE, BY RADIATION, 2018-2024 (USD MILLION)
TABLE 250. UNITED KINGDOM PANCREATIC CANCER TREATMENT MARKET SIZE, BY RADIATION, 2025-2030 (USD MILLION)
TABLE 251. UNITED KINGDOM PANCREATIC CANCER TREATMENT MARKET SIZE, BY SURGERY, 2018-2024 (USD MILLION)
TABLE 252. UNITED KINGDOM PANCREATIC CANCER TREATMENT MARKET SIZE, BY SURGERY, 2025-2030 (USD MILLION)
TABLE 253. UNITED KINGDOM PANCREATIC CANCER TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2024 (USD MILLION)
TABLE 254. UNITED KINGDOM PANCREATIC CANCER TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2025-2030 (USD MILLION)
TABLE 255. UNITED KINGDOM PANCREATIC CANCER TREATMENT MARKET SIZE, BY THERAPY LINE, 2018-2024 (USD MILLION)
TABLE 256. UNITED KINGDOM PANCREATIC CANCER TREATMENT MARKET SIZE, BY THERAPY LINE, 2025-2030 (USD MILLION)
TABLE 257. UNITED KINGDOM PANCREATIC CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 258. UNITED KINGDOM PANCREATIC CANCER TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 259. UNITED KINGDOM PANCREATIC CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 260. UNITED KINGDOM PANCREATIC CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 261. GERMANY PANCREATIC CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 262. GERMANY PANCREATIC CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 263. GERMANY PANCREATIC CANCER TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 264. GERMANY PANCREATIC CANCER TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 265. GERMANY PANCREATIC CANCER TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 266. GERMANY PANCREATIC CANCER TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 267. GERMANY PANCREATIC CANCER TREATMENT MARKET SIZE, BY PALLIATIVE CARE, 2018-2024 (USD MILLION)
TABLE 268. GERMANY PANCREATIC CANCER TREATMENT MARKET SIZE, BY PALLIATIVE CARE, 2025-2030 (USD MILLION)
TABLE 269. GERMANY PANCREATIC CANCER TREATMENT MARKET SIZE, BY RADIATION, 2018-2024 (USD MILLION)
TABLE 270. GERMANY PANCREATIC CANCER TREATMENT MARKET SIZE, BY RADIATION, 2025-2030 (USD MILLION)
TABLE 271. GERMANY PANCREATIC CANCER TREATMENT MARKET SIZE, BY SURGERY, 2018-2024 (USD MILLION)
TABLE 272. GERMANY PANCREATIC CANCER TREATMENT MARKET SIZE, BY SURGERY, 2025-2030 (USD MILLION)
TABLE 273. GERMANY PANCREATIC CANCER TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2024 (USD MILLION)
TABLE 274. GERMANY PANCREATIC CANCER TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2025-2030 (USD MILLION)
TABLE 275. GERMANY PANCREATIC CANCER TREATMENT MARKET SIZE, BY THERAPY LINE, 2018-2024 (USD MILLION)
TABLE 276. GERMANY PANCREATIC CANCER TREATMENT MARKET SIZE, BY THERAPY LINE, 2025-2030 (USD MILLION)
TABLE 277. GERMANY PANCREATIC CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 278. GERMANY PANCREATIC CANCER TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 279. GERMANY PANCREATIC CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 280. GERMANY PANCREATIC CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 281. FRANCE PANCREATIC CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 282. FRANCE PANCREATIC CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 283. FRANCE PANCREATIC CANCER TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 284. FRANCE PANCREATIC CANCER TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 285. FRANCE PANCREATIC CANCER TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 286. FRANCE PANCREATIC CANCER TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 287. FRANCE PANCREATIC CANCER TREATMENT MARKET SIZE, BY PALLIATIVE CARE, 2018-2024 (USD MILLION)
TABLE 288. FRANCE PANCREATIC CANCER TREATMENT MARKET SIZE, BY PALLIATIVE CARE, 2025-2030 (USD MILLION)
TABLE 289. FRANCE PANCREATIC CANCER TREATMENT MARKET SIZE, BY RADIATION, 2018-2024 (USD MILLION)
TABLE 290. FRANCE PANCREATIC CANCER TREATMENT MARKET SIZE, BY RADIATION, 2025-2030 (USD MILLION)
TABLE 291. FRANCE PANCREATIC CANCER TREATMENT MARKET SIZE, BY SURGERY, 2018-2024 (USD MILLION)
TABLE 292. FRANCE PANCREATIC CANCER TREATMENT MARKET SIZE, BY SURGERY, 2025-2030 (USD MILLION)
TABLE 293. FRANCE PANCREATIC CANCER TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2024 (USD MILLION)
TABLE 294. FRANCE PANCREATIC CANCER TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2025-2030 (USD MILLION)
TABLE 295. FRANCE PANCREATIC CANCER TREATMENT MARKET SIZE, BY THERAPY LINE, 2018-2024 (USD MILLION)
TABLE 296. FRANCE PANCREATIC CANCER TREATMENT MARKET SIZE, BY THERAPY LINE, 2025-2030 (USD MILLION)
TABLE 297. FRANCE PANCREATIC CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 298. FRANCE PANCREATIC CANCER TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 299. FRANCE PANCREATIC CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 300. FRANCE PANCREATIC CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 301. RUSSIA PANCREATIC CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 302. RUSSIA PANCREATIC CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 303. RUSSIA PANCREATIC CANCER TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 304. RUSSIA PANCREATIC CANCER TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 305. RUSSIA PANCREATIC CANCER TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 306. RUSSIA PANCREATIC CANCER TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 307. RUSSIA PANCREATIC CANCER TREATMENT MARKET SIZE, BY PALLIATIVE CARE, 2018-2024 (USD MILLION)
TABLE 308. RUSSIA PANCREATIC CANCER TREATMENT MARKET SIZE, BY PALLIATIVE CARE, 2025-2030 (USD MILLION)
TABLE 309. RUSSIA PANCREATIC CANCER TREATMENT MARKET SIZE, BY RADIATION, 2018-2024 (USD MILLION)
TABLE 310. RUSSIA PANCREATIC CANCER TREATMENT MARKET SIZE, BY RADIATION, 2025-2030 (USD MILLION)
TABLE 311. R

Samples

Loading
LOADING...

Companies Mentioned

  • F. Hoffmann-La Roche Ltd.
  • Eli Lilly and Company
  • Bristol-Myers Squibb Company
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer Inc.
  • AstraZeneca PLC
  • Sanofi S.A.
  • Johnson & Johnson
  • Amgen Inc.

Table Information

Report AttributeDetails
No. of Pages196
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 3.69 Billion
Forecasted Market Value ( USD ) by 2030 $ 6.86 Billion
Compound Annual Growth Rate13.3%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Pancreatic Cancer Therapeutics Market by Therapeutic Modality (Chemotherapy, Combination Therapy, Immunotherapy), Drug Class (Cellular Therapy, Monoclonal Antibody, Peptide), Treatment Line, Route Of Administration, End User - Global Forecast 2025-2030 - Product Image

Pancreatic Cancer Therapeutics Market by Therapeutic Modality (Chemotherapy, Combination Therapy, Immunotherapy), Drug Class (Cellular Therapy, Monoclonal Antibody, Peptide), Treatment Line, Route Of Administration, End User - Global Forecast 2025-2030

  • Report
  • 186 Pages
  • Global
From
Advanced Pancreatic Cancer Market - Product Image

Advanced Pancreatic Cancer Market

  • Report
  • 250 Pages
  • Global
From
Pancreatic Cancer Market Size and Share Outlook - Forecast Trends and Growth Analysis Report (2025-2034) - Product Image

Pancreatic Cancer Market Size and Share Outlook - Forecast Trends and Growth Analysis Report (2025-2034)

  • Report
  • 400 Pages
  • Global
From
Locally Advanced Pancreatic Cancer - Global Strategic Business Report - Product Image

Locally Advanced Pancreatic Cancer - Global Strategic Business Report

  • Report
  • 375 Pages
  • Global
From
Pancreatic Cancer Treatment - Global Strategic Business Report - Product Image

Pancreatic Cancer Treatment - Global Strategic Business Report

  • Report
  • 381 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.